The Full Monty: a Review of Deer and British Medical Journal’s Competing Interests in the Wakefield Affair

[Guest guest]

The Full Monty: a Review of Deer and British Medical Journal’s

Competing Interests in the Wakefield Affair

http://www.ageofautism.com/2011/08/the-full-monty-a-review-of-brian-deer-and-british-medical-journals-competing-interests-in-the-wakefi.html

Artwork by Gamondes

By Stone

The following observations are in response to Media Scholar’s query

about Deer’s competing interests

(

Age

of Autism Comment by Media Scholar).

Deer does not disclose the support he received from MedicoLegal

Investigations (an outfit allied to the Association of the British

Pharmaceutical Industry which specialises in getting doctors before the

GMC) in 2003-4 (MedicoLegal

Investigations ).

It also looks as if BMJ (with its annual pharmaceutical award ceremony)

has begun to take a relaxed view on hospitality. I suspect this goes back

to policy decisions made in 2008 when a senior BMJ editor Tony Delamothe

wrote to me:

" I can see why you think the sponsorship of his award is relevant,

but it's hardly Goldacre's fault that an outfit that has made the award

has pharma sponsorship. The BMJ Group is about to start an awards

programme of its own and some of the awards will be sponsored by pharma

companies. If we were to give you the Medical Communicator of the Year

Award (let's say, for the point of argument, sponsored by Novartis) it

wouldn't bring everything you've said into question. "

But only a year before they had published an attack by Goldacre on such

patronage and allowed comment

(BMJ Goldacre

comment). The first 2009 BMJ awards took place without pharma

patronage, but it is clear from Delamothe’s email that the they were

already in August 2008 making plans for the 2010 awards which included

sponsorship from Merck and GlaxoKline. It is against this background

that they refused to post correspondence from me earlier this year

pointing out that Deer was a guest at a pharma/GSK sponsored conference

in Baltimore last November: no doubt he was a key-note speaker

(GSK Conference Features

Deer and

actox.org Deer).

After much argument and a certain amount of circumlocution Deer does

disclose his dealings with the GMC in 2004-6. BMJ editor-in-chief, Fiona

Godlee, to her discredit refused to take action on this non-disclosure

last year but seems to have bitten on the bullet in January, but of

course the problem remains that he did not disclose the conflict to

Sunday Times readers and Channel 4 viewers at the time – obviously

a case of “what the journalist didn’t tell you”

(

Age of Autism Godlee Must Go ).

Continue reading " The Full Monty: a Review of Deer and British

Medical Journal’s Competing Interests in the Wakefield Affair " »

Posted by Age of Autism at August 03, 2011 at 5:45 AM in

Dr.

Wakefield,

Stone |

Permalink |

Comments (17)

Sheri Nakken, former R.N., MA, Hahnemannian

Homeopath

Vaccination Information & Choice Network, Washington State, USA

Vaccines -

http://vaccinationdangers.wordpress.com/ Homeopathy

http://homeopathycures.wordpress.com

Vaccine Dangers, Childhood Disease Classes & Homeopathy

Online/email courses - next classes start September 9

[Guest guest]

The Full Monty: a Review of Deer and British Medical Journal’s

Competing Interests in the Wakefield Affair

http://www.ageofautism.com/2011/08/the-full-monty-a-review-of-brian-deer-and-british-medical-journals-competing-interests-in-the-wakefi.html

Artwork by Gamondes

By Stone

The following observations are in response to Media Scholar’s query

about Deer’s competing interests

(

Age

of Autism Comment by Media Scholar).

Deer does not disclose the support he received from MedicoLegal

Investigations (an outfit allied to the Association of the British

Pharmaceutical Industry which specialises in getting doctors before the

GMC) in 2003-4 (MedicoLegal

Investigations ).

It also looks as if BMJ (with its annual pharmaceutical award ceremony)

has begun to take a relaxed view on hospitality. I suspect this goes back

to policy decisions made in 2008 when a senior BMJ editor Tony Delamothe

wrote to me:

" I can see why you think the sponsorship of his award is relevant,

but it's hardly Goldacre's fault that an outfit that has made the award

has pharma sponsorship. The BMJ Group is about to start an awards

programme of its own and some of the awards will be sponsored by pharma

companies. If we were to give you the Medical Communicator of the Year

Award (let's say, for the point of argument, sponsored by Novartis) it

wouldn't bring everything you've said into question. "

But only a year before they had published an attack by Goldacre on such

patronage and allowed comment

(BMJ Goldacre

comment). The first 2009 BMJ awards took place without pharma

patronage, but it is clear from Delamothe’s email that the they were

already in August 2008 making plans for the 2010 awards which included

sponsorship from Merck and GlaxoKline. It is against this background

that they refused to post correspondence from me earlier this year

pointing out that Deer was a guest at a pharma/GSK sponsored conference

in Baltimore last November: no doubt he was a key-note speaker

(GSK Conference Features

Deer and

actox.org Deer).

After much argument and a certain amount of circumlocution Deer does

disclose his dealings with the GMC in 2004-6. BMJ editor-in-chief, Fiona

Godlee, to her discredit refused to take action on this non-disclosure

last year but seems to have bitten on the bullet in January, but of

course the problem remains that he did not disclose the conflict to

Sunday Times readers and Channel 4 viewers at the time – obviously

a case of “what the journalist didn’t tell you”

(

Age of Autism Godlee Must Go ).

Continue reading " The Full Monty: a Review of Deer and British

Medical Journal’s Competing Interests in the Wakefield Affair " »

Posted by Age of Autism at August 03, 2011 at 5:45 AM in

Dr.

Wakefield,

Stone |

Permalink |

Comments (17)

Sheri Nakken, former R.N., MA, Hahnemannian

Homeopath

Vaccination Information & Choice Network, Washington State, USA

Vaccines -

http://vaccinationdangers.wordpress.com/ Homeopathy

http://homeopathycures.wordpress.com

Vaccine Dangers, Childhood Disease Classes & Homeopathy

Online/email courses - next classes start September 9

[Guest guest]

The Full Monty: a Review of Deer and British Medical Journal’s

Competing Interests in the Wakefield Affair

http://www.ageofautism.com/2011/08/the-full-monty-a-review-of-brian-deer-and-british-medical-journals-competing-interests-in-the-wakefi.html

Artwork by Gamondes

By Stone

The following observations are in response to Media Scholar’s query

about Deer’s competing interests

(

Age

of Autism Comment by Media Scholar).

Deer does not disclose the support he received from MedicoLegal

Investigations (an outfit allied to the Association of the British

Pharmaceutical Industry which specialises in getting doctors before the

GMC) in 2003-4 (MedicoLegal

Investigations ).

It also looks as if BMJ (with its annual pharmaceutical award ceremony)

has begun to take a relaxed view on hospitality. I suspect this goes back

to policy decisions made in 2008 when a senior BMJ editor Tony Delamothe

wrote to me:

" I can see why you think the sponsorship of his award is relevant,

but it's hardly Goldacre's fault that an outfit that has made the award

has pharma sponsorship. The BMJ Group is about to start an awards

programme of its own and some of the awards will be sponsored by pharma

companies. If we were to give you the Medical Communicator of the Year

Award (let's say, for the point of argument, sponsored by Novartis) it

wouldn't bring everything you've said into question. "

But only a year before they had published an attack by Goldacre on such

patronage and allowed comment

(BMJ Goldacre

comment). The first 2009 BMJ awards took place without pharma

patronage, but it is clear from Delamothe’s email that the they were

already in August 2008 making plans for the 2010 awards which included

sponsorship from Merck and GlaxoKline. It is against this background

that they refused to post correspondence from me earlier this year

pointing out that Deer was a guest at a pharma/GSK sponsored conference

in Baltimore last November: no doubt he was a key-note speaker

(GSK Conference Features

Deer and

actox.org Deer).

After much argument and a certain amount of circumlocution Deer does

disclose his dealings with the GMC in 2004-6. BMJ editor-in-chief, Fiona

Godlee, to her discredit refused to take action on this non-disclosure

last year but seems to have bitten on the bullet in January, but of

course the problem remains that he did not disclose the conflict to

Sunday Times readers and Channel 4 viewers at the time – obviously

a case of “what the journalist didn’t tell you”

(

Age of Autism Godlee Must Go ).

Continue reading " The Full Monty: a Review of Deer and British

Medical Journal’s Competing Interests in the Wakefield Affair " »

Posted by Age of Autism at August 03, 2011 at 5:45 AM in

Dr.

Wakefield,

Stone |

Permalink |

Comments (17)

Sheri Nakken, former R.N., MA, Hahnemannian

Homeopath

Vaccination Information & Choice Network, Washington State, USA

Vaccines -

http://vaccinationdangers.wordpress.com/ Homeopathy

http://homeopathycures.wordpress.com

Vaccine Dangers, Childhood Disease Classes & Homeopathy

Online/email courses - next classes start September 9

[Guest guest]

The Full Monty: a Review of Deer and British Medical Journal’s

Competing Interests in the Wakefield Affair

http://www.ageofautism.com/2011/08/the-full-monty-a-review-of-brian-deer-and-british-medical-journals-competing-interests-in-the-wakefi.html

Artwork by Gamondes

By Stone

The following observations are in response to Media Scholar’s query

about Deer’s competing interests

(

Age

of Autism Comment by Media Scholar).

Deer does not disclose the support he received from MedicoLegal

Investigations (an outfit allied to the Association of the British

Pharmaceutical Industry which specialises in getting doctors before the

GMC) in 2003-4 (MedicoLegal

Investigations ).

It also looks as if BMJ (with its annual pharmaceutical award ceremony)

has begun to take a relaxed view on hospitality. I suspect this goes back

to policy decisions made in 2008 when a senior BMJ editor Tony Delamothe

wrote to me:

" I can see why you think the sponsorship of his award is relevant,

but it's hardly Goldacre's fault that an outfit that has made the award

has pharma sponsorship. The BMJ Group is about to start an awards

programme of its own and some of the awards will be sponsored by pharma

companies. If we were to give you the Medical Communicator of the Year

Award (let's say, for the point of argument, sponsored by Novartis) it

wouldn't bring everything you've said into question. "

But only a year before they had published an attack by Goldacre on such

patronage and allowed comment

(BMJ Goldacre

comment). The first 2009 BMJ awards took place without pharma

patronage, but it is clear from Delamothe’s email that the they were

already in August 2008 making plans for the 2010 awards which included

sponsorship from Merck and GlaxoKline. It is against this background

that they refused to post correspondence from me earlier this year

pointing out that Deer was a guest at a pharma/GSK sponsored conference

in Baltimore last November: no doubt he was a key-note speaker

(GSK Conference Features

Deer and

actox.org Deer).

After much argument and a certain amount of circumlocution Deer does

disclose his dealings with the GMC in 2004-6. BMJ editor-in-chief, Fiona

Godlee, to her discredit refused to take action on this non-disclosure

last year but seems to have bitten on the bullet in January, but of

course the problem remains that he did not disclose the conflict to

Sunday Times readers and Channel 4 viewers at the time – obviously

a case of “what the journalist didn’t tell you”

(

Age of Autism Godlee Must Go ).

Continue reading " The Full Monty: a Review of Deer and British

Medical Journal’s Competing Interests in the Wakefield Affair " »

Posted by Age of Autism at August 03, 2011 at 5:45 AM in

Dr.

Wakefield,

Stone |

Permalink |

Comments (17)

Sheri Nakken, former R.N., MA, Hahnemannian

Homeopath

Vaccination Information & Choice Network, Washington State, USA

Vaccines -

http://vaccinationdangers.wordpress.com/ Homeopathy

http://homeopathycures.wordpress.com

Vaccine Dangers, Childhood Disease Classes & Homeopathy

Online/email courses - next classes start September 9